Skip to content

Serological Indicators Facilitate the Diagnosis of Fetal Intrauterine Distress

Serological Indicators Facilitate the Diagnosis of Fetal Intrauterine Distress

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101931
Enrollment
Unknown
Registered
2025-05-06
Start date
2025-05-15
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal intrauterine distress

Interventions

No fetal intrauterine distress group:None
Fetal intrauterine distress group:None

Sponsors

Guangdong Province Hospital for Women and Children Healthcare
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1.Year: January 2022 to July 2024; 2.Control group: Pregnant women aged 22-42 years, without fetal distress, and with multiple serological test results who come to the hospital for treatment; 3.Case group: Pregnant women aged 22-42 years old who have been diagnosed with fetal intrauterine distress and have multiple serological test results come to the hospital for treatment.

Exclusion criteria

Exclusion criteria: 1.Age42 years old; 2.Pregnant women who come to the hospital for treatment without results of serological related indicators.

Design outcomes

Primary

MeasureTime frame
Fetal intrauterine distress;Maternal serological parameters;

Countries

China

Contacts

Public ContactHongyu Li

Guangdong Province Hospital for Women and Children Healthcare

leehongyuuu@163.com+86 13516517589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026